TGFB1 and polyostotic fibrous dysplasia: Therefore, HLFs in this study were exposed to TGF-β1 to induce cell phenotypic transformation, and then treated with PFD or β-catenin, so as to further explore the cellular and molecular mechanism of PFD treatment in pulmonary fibrosis.